Simeprevir is an Orally Active HCV NS3/4A Protease Inhibitor
Hepatitis C is a blood-borne infection that can ultimately result in severe liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. The chronic nature of the disease and the significant possibility…